In addition, the rate of decline of inflammatory mediators such as CRP during exacerbations of COPD is significantly diminished compared to other inflammatory conditions such as pneumonia, with only 6% of COPD patients responding by CRP reductions on the second day of hospitalization following antibiotic administration [27]. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.